SCHEMBL7185064

SCHEMBL7185064

CC1C(=O)Nc2ccc(Oc3ccc(-c4cccc(C=CC(=O)O)c4)c(Br)c3Br)cc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 2/20 0.37
KDM4E B2RXH2 3/20 0.34
ALDH1A1 P00352 3/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
CYP4F2 P78329 2/20 0.33
CYP4A11 Q02928 2/20 0.33
POLB P06746 1/20 0.33
RXRA P19793 1/20 0.33
NR4A2 P43354 1/20 0.33
PIM2 Q9P1W9 2/20 0.32
HPGD P15428 1/20 0.32
ALOX15 P16050 1/20 0.32
MAPK1 P28482 1/20 0.32
HSD17B10 Q99714 1/20 0.32
RHOA P61586 1/20 0.32
PIM1 P11309 1/20 0.32
PIM3 Q86V86 1/20 0.32
THRB P10828 1/20 0.32
HTT P42858 1/20 0.32
PKM P14618 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5394461 0.68 AKR1B1 (0.37) KDM4ESMN1; SMN2ESR1ESR2MEN1
SCHEMBL4354279 0.67 MEN1 (0.37) PGRALDH1A1POLBTHRBMEN1
SCHEMBL7174069 0.65 THRB (0.46) KDM4EALDH1A1SMN1; SMN2POLBRXRA
SCHEMBL28503676 0.64 KDM4E (0.56) KDM4EALDH1A1SMN1; SMN2RXRANR4A2
SCHEMBL5389009 0.62 THRA (0.39) PGRALOX15HSD17B10THRBKMT2A
SCHEMBL15730582 0.61 MAOA (0.51) PGRALDH1A1POLB
SCHEMBL28498982 0.61 THRB (0.64) KDM4EALDH1A1SMN1; SMN2PIM2HPGD
SCHEMBL27684130 0.61 THRB (0.64) KDM4EALDH1A1SMN1; SMN2PIM2HPGD
SCHEMBL6913211 0.61 PGR (0.36) PGRPOLBMAPK1THRB
SCHEMBL8937421 0.60 KDM4E (0.70) KDM4EALDH1A1SMN1; SMN2HPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1296936-A1 THYROID RECEPTOR LIGANDS, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND THEIR USE IN THE TREATMENT OF DISORDERS INFLUENCED BY THYROID HORMONES KARO BIO AB (SE) 2003-04-02 EP disclosed
WO-2001098256-A1 THYROID RECEPTOR LIGANDS, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND THEIR USE IN THE TREATMENT OF DISORDERS INFLUENCED BY THYROID HORMONES KARO BIO AB (SE) 2001-12-27 WO disclosed